Vantis

Vantis

Private
MunichHealthcare & Life Scienceshttps://vantis-health.com

Last Round

Series A

Mar 12, 2025

Total Funding Raised

$15.5M

Company Overview

Vantis is a health-tech company that provides holistic primary healthcare services for chronic diseases through a hybrid model of digital health applications and a network of its own medical practices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Telemedicine, EHR & EMR

Business Model

B2B2C

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

hybrid caredigital therapeuticsDiGAchronic disease managementApp auf RezeptDTxprimary care practicesvertically integrated healthcarehealth insurance reimbursementcardiovascular diseasetelemedicinehypertension managementcoronary heart diseaseGerman healthcare marketB2B2C healthcareremote patient monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vantis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vantis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 12, 2025
SeedMay 3, 2021

Key People

Founding team and executive leadership

Till Jansen

CEO Founder

Founding Team

Vantis Investors

Notable investors and investment history

InvestorRounds
Firstminute CapitalSeries A, Seed
Twip Impact VenturesSeries A
Angelini VenturesSeries A
b2ventureSeries A, Seed
Bayern KapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2025

    $11M round completed.

  • Feb 8, 2025

    Reached 150 employees in the medical field.

Vantis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vantis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vantis's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range37
Year Founded2019
Last FundingMar 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.